Virscio is a specialty translational research organization developing and providing innovative in vivo disease modeling and related preclinical research and development services to meet the preclinical, translational, and regulatory research needs of the pharmaceutical and life sciences industry. We specialize in the fields of ophthalmology, central nervous system, cardiovascular and metabolic related disease and disorders, and have advanced discovery and development programs for a wide range of sponsors, collaborators, and partners around the world, ranging from large pharmaceutical companies and venture-backed biotechnology companies to academic teams seeking to apply the most cutting edge research and development strategies in the most efficient and robust manner.
Company Details
- Employees
- 78
- Founded
- 2002
- Address
- 4 Science Park, New Haven,ct,united States
- Phone
- 2037762893
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- virscio.com
- Keywords
- Toxicology Study, Safety Pharmacology, Preclinical Study, GLP / Non-GLP Study, IND-Enabling, Research Support Services, Drug Development, Pharmaceutical Research.
- HQ
- New Haven, CT
Virscio Questions
Virscio's helpline number is 2037762893
Virscio's website is virscio.com
Virscio's LinkedIn profile is https://www.linkedin.com/company/virscioprofile
Virscio has
78 employees.
View email and phone details for 78
employees at Virscio.
Virscio's industry is
Biotechnology Research
Virscio's top competitors are
Labcorp,
Trevi Therapeutics, Inc.,
Biohaven,
Halda Therapeutics,
Alphina Therapeutics,
Arvinas,
Exhaura, Ltd.,
Cybrexa Therapeutics,
Charles River Laboratories,
Ascend Imaging.
Virscio's categories are Biotechnology Research
Virscio's founding year is 2002
